Research Team

Chantal Lambert-Harris, MA

Research Scientist, Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth; Project Manager, Northeast Node of the National Drug Abuse Treatment Clinical Trials Network

Research Supervision and Management; Regulatory Guidelines and Policies; Co-Occurring Substance Use and Mental Health Disorders; Opioid Use Disorder

Contact

Chantal Lambert-Harris, MA
Research Scientist, Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth; Project Manager, Northeast Node of the National Drug Abuse Treatment Clinical Trials Network

46 Centerra Parkway, Suite 300, Lebanon, NH 03766

603-646-7007

Chantal.A.Lambert-Harris@Dartmouth.edu


Ms. Lambert-Harris began her professional career as a Technical IRTA Fellow at the National Institute of Mental Health and working as a Graduate Research Assistant for the Cognitive Science Laboratory at The Catholic University of America. During her time in Washington, DC, Ms. Lambert-Harris assisted with the coordination and database management of a longitudinal study investigating attention and working memory among people at risk for developing Alzheimer’s disease. After completing her graduate studies, Ms. Lambert-Harris worked as a Project Coordinator at the Dartmouth Psychiatric Research Center (PRC). From 2005 to 2016, Ms. Lambert-Harris managed and/or coordinated all aspects of several federally funded studies, including Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institute on Drug Abuse (NIDA), and National Institute on Alcohol Abuse and Alcoholism (NIAAA). In addition to her study management/coordination role, she was the Managing Editor of the Journal of Substance Abuse Treatment. Beginning in 2016, Ms. Lambert-Harris served as Research Manager for the Dartmouth Synergy Clinical Research Unit (CRU) in Manchester, NH. She was charged with overseeing all aspects of the CRU’s operations, including outfitting the unit, developing SOPs, reviewing and generating study budgets, and collaborating with researchers from multiple departments and organizations (i.e., nursing, investigational pharmacy, government and industry sponsors, and Principal Investigators). Currently, she is a Research Scientist and Project Manager with the Northeast Node of the Clinical Trials Network and the Center for Technology and Behavioral Health. In her spare time, she enjoys hiking, traveling, and spending time with her family.


Selected Publications
  • type-published
    1456790400
    3
    2016
    Nordstrom BR, Saunders EC, McLeman B, Meier A, Xie H, Lambert-Harris C, Tanzman B, Brooklyn J, King G, Kloster N, Lord CF, Roberts W, McGovern MP. Using a learning collaborative strategy with office-based practices to increase access and improve quality of care for patients with opioid use disorders. J Addict Med. 2016 Mar-Apr;10(2):117-23. doi: 10.1097/ADM.0000000000000200. PMID: 26900669; PMCID: PMC4865252.
    View Source
  • type-published
    1448928000
    12
    2015
    Saunders EC, McGovern MP, Lambert-Harris C, Meier A, McLeman B, Xie H. The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict. 2015 Dec;24(8):722-31. doi: 10.1111/ajad.12292. PMID: 26388539; PMCID: PMC4866634.
    View Source
  • type-published
    1439856000
    8
    2015
    Meier A, McGovern MP, Lambert-Harris C, McLeman B, Franklin A, Saunders EC, Xie H. Adherence and competence in two manual-guided therapies for co-occurring substance use and posttraumatic stress disorders: Clinician factors and patient outcomes. Am J Drug Alcohol Abuse. 2015;41(6):527-34. doi: 10.3109/00952990.2015.1062894. PMID: 26286351; PMCID: PMC4698972.
    View Source
  • type-published
    1435708800
    7
    2015
    McGovern MP, Lambert-Harris C, Xie H, Meier A, McLeman B, Saunders E. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251; PMCID: PMC4478141.
    View Source
  • type-published
    1422748800
    2
    2015
    Saunders EC, McLeman BM, McGovern MP, Xie H, Lambert-Harris C, Meier A. The influence of family and social problems on treatment outcomes of persons with co-occurring substance use disorders and PTSD. J Subst Use. 2016;21(3):237-243. doi: 10.3109/14659891.2015.1005184. PMID: 27182200; PMCID: PMC4864012.
    View Source
  • type-published
    1420070400
    1
    2015
    Saunders EC, Lambert-Harris C, McGovern MP, Meier A, Xie H. The prevalence of posttraumatic stress disorder symptoms among addiction treatment patients with cocaine use disorders. J Psychoactive Drugs. 2015 Jan-Mar;47(1):42-50. doi: 10.1080/02791072.2014.977501. PMID: 25715071; PMCID: PMC4876862.
    View Source
  • type-published
    1410220800
    9
    2014
    Lambert-Harris C, McGovern MP, Saunders EC, Hoyt J. A manual-guided therapy for co-occurring substance use and psychiatric disorders delivered by community addiction counselors: Are outcomes different from psychotherapy delivered by mental health professionals? J Addict Behav Ther Rehabil 3:3. doi:10.4172/2324-9005.1000127
    View Source
  • type-published
    1404172800
    7
    2014
    Meier A, Lambert-Harris C, McGovern MP, Xie H, An M, McLeman B. Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity. Am J Drug Alcohol Abuse. 2014 Jul;40(4):304-11. doi: 10.3109/00952990.2014.910519. PMID: 24809229; PMCID: PMC4883674.
    View Source
  • type-published
    1393632000
    3
    2014
    McGovern MP, Lambert-Harris C, Gotham HJ, Claus RE, Xie H. Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems. Adm Policy Ment Health. 2014 Mar;41(2):205-14. doi: 10.1007/s10488-012-0449-1. PMID: 23183873; PMCID: PMC3594447.
    View Source
  • type-published
    1356998400
    1
    2013
    Lambert-Harris C, Saunders EC, McGovern MP, Xie H. Organizational capacity to address co-occurring substance use and psychiatric disorders: Assessing variation by level of care. J Addict Med. 2013 Jan-Feb;7(1):25-32. doi: 10.1097/ADM.0b013e318276e7a4. PMID: 23188042.
    View Source